Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients – BMC…

World Health Organization. WHO coronavirus (COVID-19) Dashboard. https://covid19.who.int/. Accessed 24 Mar 2022.

Haque A, Pant AB. Mitigating COVID-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy. J Autoimmun. 2022;127:102792.

CAS Article Google Scholar

Inaba H, Aizawa T. Coronavirus disease 2019 and the thyroid - progress and perspectives. Front Endocrinol (Lausanne). 2021;12:708333.

Article Google Scholar

Murugan AK, Alzahrani AS. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Gravesdisease. Endocrine. 2021;73(2):24354.

CAS Article Google Scholar

Knack RS, Hanada T, Knack RS, Mayr K. Hashimotos thyroiditis following SARS-CoV-2 infection. BMJ Case Rep. 2021;14(8):e244909.

Article Google Scholar

Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):102731.

CAS Article Google Scholar

Lui DTW, Lee KK, Lee CH, Lee ACH, Hung IFN, Tan KCB. Development of Graves disease after SARS-CoV-2 mRNA vaccination: a case report and literature review. Front Public Health. 2021;9:778964.

Article Google Scholar

di Filippo L, Castellino L, Giustina A. Occurrence and response to treatment of Graves disease after COVID vaccination in two male patients. Endocrine. 2022;75(1):1921.

Article Google Scholar

Giusti M, Maio A. Acute thyroid swelling with severe hypothyroid myxoedema after COVID-19 vaccination. Clin Case Rep. 2021;9(12):e05217.

Article Google Scholar

Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2020;11:617089.

CAS Article Google Scholar

Watad A, David P, Brown S, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants and thyroid autoimmunity. Front Endocrinol (Lausanne). 2016;7:150.

Google Scholar

Jafarzadeh A, Nemati M, Jafarzadeh S, Nozari P, Mortazavi SMJ. Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence. J Endocrinol Invest. 2022:129. https://doi.org/10.1007/s40618-022-01786-7.

Cheung KS, Chen L, Chan EW, Seto WK, Wong ICK, Leung WK. Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients. Gut. 2019;68(11):197985.

CAS Article Google Scholar

Xiong X, Wong CKH, Au ICH, Lai FTT, Li X, Wan EYF, et al. Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study. Thyroid. 2022;32(5):50514.

CAS Article Google Scholar

Li X, Tong X, Yeung WWY, Kuan P, Yum SHH, Chui CSL, et al. Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong. Ann Rheum Dis. 2022;81(4):5648.

CAS Article Google Scholar

Wan EYF, Chui CSL, Lai FTT, Chan EWY, Li X, Yan VKC, et al. Bells palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet Infect Dis. 2022;22(1):6472.

CAS Article Google Scholar

Chua GT, Kwan MYW, Chui CSL, Smith RD, Cheung EC, Tian T, et al. Epidemiology of acute myocarditis/pericarditis in hong kong adolescents following comirnaty vaccination. Clin Infect Dis. 2021. https://doi.org/10.1093/cid/ciab989.

Lai FTT, Li X, Peng K, Huang L, Ip P, Tong X, et al. Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine : a case-control study. Ann Intern Med. 2022;175(3):36270.

Article Google Scholar

Sing CW, Tang CTL, Chui CSL, Fan M, Lai FTT, Li X, et al. COVID-19 vaccines and risks of hematological abnormalities: nested case-control and self-controlled case series study. Am J Hematol. 2022;97(4):47080.

CAS Article Google Scholar

Wan EYF, Chui CSL, Wang Y, Ng VWS, Yan VKC, Lai FTT, et al. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study. Lancet Reg Health West Pac. 2022;21:100393.

Article Google Scholar

Wong CKH, Xiong X, Lau KTK, Chui CSL, Lai FTT, Li X, et al. Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization. BMC Med. 2022;20(1):119.

CAS Article Google Scholar

Lai FTT, Huang L, Chui CSL, Wan EYF, Li X, Wong CKH, et al. Multimorbidity and adverse events of special interest associated with COVID-19 vaccines in Hong Kong. Nat Commun. 2022;13(1):411.

CAS Article Google Scholar

Lai FTT, Huang L, Peng K, Li X, Chui CSL, Wan EYF, et al. Post-COVID-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection. J Intern Med. 2022;291(6):8649.

CAS Article Google Scholar

Lai FTT, Chua GT, Chan EWW, Huang L, Kwan MYW, Ma T, et al. Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study. Emerg Microbes Infect. 2022;11(1):88593.

CAS Article Google Scholar

Li X, Tong X, Wong ICK, Peng K, Chui CSL, Lai FTT, et al. Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study. Gut. 2022. https://doi.org/10.1136/gutjnl-2021-326860.

Chui CSL, Fan M, Wan EYF, Leung MTY, Cheung E, Yan VKC, et al. Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: a self-controlled case series study. EClinicalMedicine. 2022;50:101504.

Article Google Scholar

Wong CKH, Mak LY, Au ICH, Lai FTT, Li X, Wan EYF, et al. Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines. J Hepatol. 2022. https://doi.org/10.1016/j.jhep.2022.06.032.

Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol. 1996;143(11):116573.

CAS Article Google Scholar

Hippisley-Cox J, Patone M, Mei XW, Saatci D, Dixon S, Khunti K, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021;374:n1931.

Article Google Scholar

Simpson CR, Shi T, Vasileiou E, Katikireddi SV, Kerr S, Moore E, et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med. 2021;27(7):12907.

CAS Article Google Scholar

Li X, Ravents B, Roel E, Pistillo A, Martinez-Hernandez E, Delmestri A, et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. 2022;376:e068373.

Article Google Scholar

Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):214453.

CAS Article Google Scholar

Sahin Tekin M, Saylisoy S, Yorulmaz G. Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report. Hum Vaccin Immunother. 2021;17(11):40902.

CAS Article Google Scholar

Zettinig G, Krebs M. Two further cases of Graves disease following SARS-Cov-2 vaccination. J Endocrinol Invest. 2022;45(1):2278.

CAS Article Google Scholar

Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016;354:i4515.

Article Google Scholar

Yonas GW, Heather W, Paddy F. The self-controlled case series method: The Comprehensive R Archive Network; 2022. https://cran.r-project.org/web/packages/SCCS/SCCS.pdf. Accessed 24 Aug 2022

Google Scholar

Ghebremichael-Weldeselassie Y, Jabagi MJ, Botton J, Bertrand M, Baricault B, Drouin J, et al. A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety. Stat Med. 2022;41(10):173550.

Article Google Scholar

Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Snchez Valadez TI, Jara LJ. Two cases of Graves disease following SARS-CoV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. Thyroid. 2021;31(9):14369.

CAS Article Google Scholar

Pokhrel B, Bhusal K. Graves disease: StatPearls Publishing. Treasure Island (FL); 2022.

Google Scholar

Smith TJ, Hegeds L. Graves disease. N Engl J Med. 2016;375(16):155265.

Article Google Scholar

Chee YJ, Liew H, Hoi WH, Lee Y, Lim B, Chin HX, et al. SARS-CoV-2 mRNA vaccination and Graves disease: a report of 12 cases and review of the literature. J Clin Endocrinol Metab. 2022;107(6):e232430.

Article Google Scholar

Yorulmaz G, Sahin Tekin M. SARS-CoV-2 vaccine-associated subacute thyroiditis. J Endocrinol Invest. 2022;45(7):13417.

CAS Article Google Scholar

Oguz SH, Sendur SN, Iremli BG, Gurlek A, Erbas T, Unluturk U. SARS-CoV-2 vaccine-induced thyroiditis: safety of revaccinations and clinical follow-up. J Clin Endocrinol Metab. 2022;107(5):e182334.

Article Google Scholar

Paschou SA, Karalis V, Psaltopoulou T, Vasileiou V, Charitaki I, Bagratuni T, et al. Patients with autoimmune thyroiditis present similar immunological response to COVID-19 BNT162b2 mRNA vaccine with healthy subjects, while vaccination may affect thyroid function: a clinical study. Front Endocrinol (Lausanne). 2022;13:840668.

Article Google Scholar

Sriphrapradang C, Shantavasinkul PC. Graves disease following SARS-CoV-2 vaccination. Endocrine. 2021;74(3):4734.

CAS Article Google Scholar

Read the original:

Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients - BMC...

Related Posts
Tags: